110 related articles for article (PubMed ID: 23282898)
1. Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone-sialic acid hybrids.
Aoki Y; Tanimoto S; Takahashi D; Toshima K
Chem Commun (Camb); 2013 Feb; 49(12):1169-71. PubMed ID: 23282898
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution.
Rameix-Welti MA; Munier S; Le Gal S; Cuvelier F; Agou F; Enouf V; Naffakh N; van der Werf S
Antivir Ther; 2011; 16(4):597-603. PubMed ID: 21685548
[TBL] [Abstract][Full Text] [Related]
3. Photodegradation of lipopolysaccharides and the inhibition of macrophage activation by anthraquinone-boronic acid hybrids.
Takahashi D; Miura T; Toshima K
Chem Commun (Camb); 2012 Aug; 48(61):7595-7. PubMed ID: 22733145
[TBL] [Abstract][Full Text] [Related]
4. Degradation of target oligosaccharides by anthraquinone-lectin hybrids with light switching.
Imai Y; Hirono S; Matsuba H; Suzuki T; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K
Chem Asian J; 2012 Jan; 7(1):97-104. PubMed ID: 21997955
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Liu H; Yao X; Wang C; Han J
Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
[TBL] [Abstract][Full Text] [Related]
6. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.
Dao TT; Nguyen PH; Lee HS; Kim E; Park J; Lim SI; Oh WK
Bioorg Med Chem Lett; 2011 Jan; 21(1):294-8. PubMed ID: 21123068
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
[TBL] [Abstract][Full Text] [Related]
8. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.
Márquez-Domínguez L; Reyes-Leyva J; Herrera-Camacho I; Santos-López G; Scior T
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947893
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
[TBL] [Abstract][Full Text] [Related]
10. Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera.
Suzuki T; Tsukimoto M; Kobayashi M; Yamada A; Kawaoka Y; Webster RG; Suzuki Y
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1769-74. PubMed ID: 7517433
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
Wang YT; Chan CH; Su ZY; Chen CL
Biophys Chem; 2010 Mar; 147(1-2):74-80. PubMed ID: 20045243
[TBL] [Abstract][Full Text] [Related]
12. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
Okomo-Adhiambo M; Hurt AC; Gubareva LV
Methods Mol Biol; 2012; 865():95-113. PubMed ID: 22528155
[TBL] [Abstract][Full Text] [Related]
13. Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.
Rudrawar S; Dyason JC; Maggioni A; Thomson RJ; von Itzstein M
Bioorg Med Chem; 2013 Aug; 21(16):4820-30. PubMed ID: 23800724
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
Ferraris O; Kessler N; Lina B
Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
[TBL] [Abstract][Full Text] [Related]
15. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
16. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
[TBL] [Abstract][Full Text] [Related]
17. H1N1 influenza A virus neuraminidase modulates infectivity in mice.
Ferraris O; Escuret V; Bouscambert M; Casalegno JS; Jacquot F; Raoul H; Caro V; Valette M; Lina B; Ottmann M
Antiviral Res; 2012 Mar; 93(3):374-80. PubMed ID: 22321413
[TBL] [Abstract][Full Text] [Related]
18. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
19. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
[TBL] [Abstract][Full Text] [Related]
20. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
